Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Exchange Rate Effect (2021 - 2025)

Amylyx Pharmaceuticals (AMLX) has 5 years of Exchange Rate Effect data on record, last reported at $118000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 122.48% year-over-year to $118000.0; the TTM value through Dec 2025 reached $1.1 million, up 345.21%, while the annual FY2025 figure was $1.1 million, 345.21% up from the prior year.
  • Exchange Rate Effect reached $118000.0 in Q4 2025 per AMLX's latest filing, down from $151000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $608000.0 in Q2 2025 and bottomed at -$525000.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $41222.2, with a median of $5500.0 recorded in 2021.
  • The widest YoY moves for Exchange Rate Effect: up 5533.33% in 2022, down 18550.0% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $9000.0 in 2021, then surged by 5533.33% to $507000.0 in 2022, then plummeted by 53.25% to $237000.0 in 2023, then tumbled by 321.52% to -$525000.0 in 2024, then soared by 122.48% to $118000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $118000.0 in Q4 2025, $151000.0 in Q3 2025, and $608000.0 in Q2 2025.